PL2937084T3 - Sposób leczenia hipercholesterolemii - Google Patents

Sposób leczenia hipercholesterolemii

Info

Publication number
PL2937084T3
PL2937084T3 PL14167512T PL14167512T PL2937084T3 PL 2937084 T3 PL2937084 T3 PL 2937084T3 PL 14167512 T PL14167512 T PL 14167512T PL 14167512 T PL14167512 T PL 14167512T PL 2937084 T3 PL2937084 T3 PL 2937084T3
Authority
PL
Poland
Prior art keywords
hypercholesterolemia
treatment
Prior art date
Application number
PL14167512T
Other languages
English (en)
Polish (pl)
Inventor
Muhammed Majeed
Kalyanam Nagabhushanam
Anju Majeed
Sarang Bani
Anjali Pandey
Original Assignee
Muhammed Majeed
Kalyanam Nagabhushanam
Anju Majeed
Sarang Bani
Anjali Pandey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muhammed Majeed, Kalyanam Nagabhushanam, Anju Majeed, Sarang Bani, Anjali Pandey filed Critical Muhammed Majeed
Publication of PL2937084T3 publication Critical patent/PL2937084T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL14167512T 2014-04-23 2014-05-08 Sposób leczenia hipercholesterolemii PL2937084T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/259,404 US9668999B2 (en) 2014-04-23 2014-04-23 Method for the treatment of hypercholesterolemia
EP14167512.4A EP2937084B1 (en) 2014-04-23 2014-05-08 Method for the treatment of hypercholesterolemia

Publications (1)

Publication Number Publication Date
PL2937084T3 true PL2937084T3 (pl) 2017-05-31

Family

ID=50828681

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14167512T PL2937084T3 (pl) 2014-04-23 2014-05-08 Sposób leczenia hipercholesterolemii

Country Status (11)

Country Link
US (2) US9668999B2 (enExample)
EP (1) EP2937084B1 (enExample)
JP (1) JP6263707B2 (enExample)
KR (1) KR101647549B1 (enExample)
AU (1) AU2014202312B2 (enExample)
CA (2) CA2850999C (enExample)
EA (1) EA027148B1 (enExample)
MY (1) MY170067A (enExample)
PH (1) PH12014000244A1 (enExample)
PL (1) PL2937084T3 (enExample)
TW (1) TWI622394B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201503805XA (en) * 2015-04-19 2016-11-29 Sabinsa Corp Calebin A For Hepatic Steatosis
US9539232B1 (en) * 2016-08-04 2017-01-10 Muhammed Majeed Calebin A for osteoporosis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060352C (zh) * 1996-02-08 2001-01-10 袁克兴 降脂药及其制备方法
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
WO2001030335A2 (en) * 1999-10-22 2001-05-03 The Board Of Trustees Of The University Of Illinois Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
US20020012733A1 (en) 2000-04-12 2002-01-31 The Procter & Gamble Company Compositions for reducing hypercholesterolemia and controlling of postprandial blood glucose and insulin levels
JP2005232059A (ja) * 2004-02-18 2005-09-02 Iichiro Shimomura 低アディポネクチン血症予防・治療剤
JP4834824B2 (ja) * 2004-07-08 2011-12-14 独立行政法人産業技術総合研究所 アディポネクチン産生増強剤
JP2010018522A (ja) * 2007-03-23 2010-01-28 Hiroshima Univ アディポネクチン産生促進剤
JP5294165B2 (ja) * 2007-03-23 2013-09-18 ナガセケムテックス株式会社 アディポネクチン上昇剤
CN101301455A (zh) * 2008-07-01 2008-11-12 崔井朝 一种治疗高脂血症的中药复方姜黄固体分散体
JP2011063543A (ja) * 2009-09-17 2011-03-31 Kao Corp アディポネクチン増加剤
KR101702702B1 (ko) * 2011-01-10 2017-02-03 무하메드 마제에드 칼레빈 ａ의 항-비만 가능성

Also Published As

Publication number Publication date
KR20150122552A (ko) 2015-11-02
US9610273B2 (en) 2017-04-04
CA2963383C (en) 2018-12-04
KR101647549B1 (ko) 2016-08-10
NZ624269A (en) 2014-12-24
TW201540295A (zh) 2015-11-01
MY170067A (en) 2019-07-03
CA2850999A1 (en) 2015-10-23
PH12014000244B1 (en) 2016-08-08
EA201491545A1 (ru) 2015-10-30
EP2937084A1 (en) 2015-10-28
JP2015209424A (ja) 2015-11-24
US9668999B2 (en) 2017-06-06
TWI622394B (zh) 2018-05-01
JP6263707B2 (ja) 2018-01-24
CA2963383A1 (en) 2015-10-23
AU2014202312B2 (en) 2018-02-22
CA2850999C (en) 2018-04-03
EA027148B1 (ru) 2017-06-30
PH12014000244A1 (en) 2016-08-08
AU2014202312A1 (en) 2015-11-12
US20150306060A1 (en) 2015-10-29
US20150306059A1 (en) 2015-10-29
EP2937084B1 (en) 2016-11-30
HK1210590A1 (en) 2016-04-29

Similar Documents

Publication Publication Date Title
IL279627A (en) A method for treating depression
IL247515A0 (en) Snekribirock for the treatment of leprosy
GB201701673D0 (en) Methods of well treatment
PL3286311T3 (pl) Sposób leczenia nowotworów złośliwych
IL247155A0 (en) Rapamycin for the treatment of lymphangioleiomyomatosis
IL248856B (en) New treatment
GB201410116D0 (en) Method of treatment
GB201401430D0 (en) Treatment process
IL253028A0 (en) treatment method
GB201416832D0 (en) Methods of treatment
SG11201702700UA (en) Methods for the treatment of peri-implantitis
IL253617A0 (en) Snekribirock for the treatment of leprosy
IL247443B (en) Process for the preparation of 5-fluorotryptophol
PL3023210T3 (pl) Sposób obróbki materiału sypkiego
EP3202349A4 (en) Treatment apparatus
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
PL2937084T3 (pl) Sposób leczenia hipercholesterolemii
GB2534681B (en) Treatment apparatus
SG11201706885RA (en) Novel treatment method
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
GB201421980D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment
GB201415331D0 (en) Method of treatment
GB201414780D0 (en) Method Of Treatment